Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

[1]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[2]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[3]  O. Vaarala.  Binding profiles of anticardiolipin antibodies in sera from patients with SLE and infectious diseases. , 1991, Journal of autoimmunity.

[4]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J L Witztum,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[6]  D. Brown,et al.  Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. , 1990, Archives of pathology & laboratory medicine.

[7]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Hughes,et al.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. , 1987, Clinical and experimental immunology.

[9]  G. Daggard,et al.  CORONARY ARTERY BYPASS GRAFT FAILURE—AN AUTOIMMUNE PHENOMENON? , 1986, The Lancet.

[10]  C. Chesterman,et al.  Immunology and clinical importance of antiphospholipid antibodies. , 1991, Advances in immunology.